Search Results - Helge Bischoff

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Major clinical benefit from adjuvant chemotherapy for stage II–III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis by Miriam Blasi, Martin E. Eichhorn, Petros Christopoulos, Hauke Winter, Claus Peter Heußel, Felix J. Herth, Rami El Shafie, Katharina Kriegsmann, Mark Kriegsmann, Albrecht Stenzinger, Helge Bischoff, Michael Thomas, Jonas Kuon

    Published in BMC Pulmonary Medicine (2022-06-01)
    Get full text
    Article


  2. 2

    Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: results of the NEOMUN trial by Albrecht Stenzinger, Dirk Jäger, Michael Thomas, Hauke Winter, Helge Bischoff, Uwe Haberkorn, Felix Herth, Pornpimol Charoentong, Petros Christopoulos, Rajkumar Savai, Laura V Klotz, Raffaella Griffo, Martin E Eichhorn, Florian Eichhorn, Benedikt Niedermaier, Philip Baum, Michael Allgäuer, Marc A Schneider, Claus-Peter Heußel, Maria Paula Roberti, Inka Zoernig

    Published in Journal for ImmunoTherapy of Cancer (2025-08-01)
    Get full text
    Article


  3. 3

    Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with s... by Alexandros Papachristofilou, Madeleine M. Hipp, Ute Klinkhardt, Martin Früh, Martin Sebastian, Christian Weiss, Miklos Pless, Richard Cathomas, Wolfgang Hilbe, Georg Pall, Thomas Wehler, Jürgen Alt, Helge Bischoff, Michael Geißler, Frank Griesinger, Karl-Josef Kallen, Mariola Fotin-Mleczek, Andreas Schröder, Birgit Scheel, Anke Muth, Tobias Seibel, Claudia Stosnach, Fatma Doener, Henoch S. Hong, Sven D. Koch, Ulrike Gnad-Vogt, Alfred Zippelius

    Published in Journal for ImmunoTherapy of Cancer (2019-02-01)
    Get full text
    Article


Search Tools: